- Investing Ideas
- Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
1 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Eris Lifesciences
Market Cap: ₹190.5b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
New
ERIS
₹1,375.10
7D
-3.6%
1Y
-20.3%
Alembic Pharmaceuticals
Market Cap: ₹160.8b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹818.20
7D
0.8%
1Y
-13.7%
Dr. Reddy's Laboratories
Market Cap: ₹977.9b
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,174.00
7D
2.7%
1Y
-1.9%